AIDS Pandemic Provokes Alarming Reassessments Of Infectious Disease

In 1900, infectious disease was the leading cause of mortality in the United States, accounting for at least 37 percent of deaths. By 1950, this had been mitigated to 6.8 percent and, by 1989, to 2.8 percent, with corresponding improvements in life expectancy. These numbers, of course, must be taken with a grain of salt, given the eventual preemptive role of infection in chronic illness, and many disorders whose infectious etiology is still to be recognized. Further, the relative importance

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Further, the relative importance of sanitation, health education, and nutrition--in contrast to medical interventions like immunization and antibiotics--has remained in contentious debate. Regardless, this achievement is trumpeted as the conquest of infectious disease--a glorious tribute, indeed, to public health and medical science.

In consequence, health research since 1950 has ever more emphasized chronic constitutional afflictions like cancer, cardiovascular disease, and psychiatric disorders to the relative neglect of infection. Environmental anxieties are focused on radiation and chemical toxins rather than arthropod vectors and airborne contagion.

Our complacency over the triumph of the human over the microbial has been shaken by the global HIV pandemic. In truth, the majority of the world's population has never been relieved of its load of malaria, tuberculosis, diarrheal disease, and a host of parasitoses. It has taken AIDS to provoke a new look at the threats to human health in the U.S. from infections recently thought ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Joshua Lederberg

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo